Skip to main content
. 2012 Nov 14;12:516. doi: 10.1186/1471-2407-12-516

Figure 2.

Figure 2

Breast cancer specific survival by Kaplan-Meier analysis. Overall, the patients with GASC1 immunopositive tumors have better survival than the patients with GASC1 negative tumors (p=0.017 Log Rank; p=0.012, Breslow; p=0.013, Tarone-Ware).